Julie A Stone Selected Research

Neoplasms (Cancer)

1/2019	Immunogenicity of pembrolizumab in patients with advanced tumors.
12/2018	Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance.
10/2017	Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Stone Research Topics

Disease

5	Body Weight (Weight, Body) 10/2023 - 11/2005
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2019 - 01/2017
4	Neutropenia 05/2011 - 05/2005
3	COVID-19 01/2024 - 01/2023
3	Bone Resorption 10/2020 - 05/2013
3	Osteoporosis 01/2020 - 05/2013
3	Neoplasms (Cancer) 01/2019 - 10/2017
3	Hepatic Insufficiency 10/2011 - 08/2007
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 10/2017
2	Invasive Candidiasis 05/2011 - 05/2005
2	Aspergillosis 05/2011 - 05/2005
2	Fever (Fevers) 05/2011 - 04/2009
2	Mycoses (Diseases, Fungus) 02/2011 - 03/2002
2	Candidiasis (Moniliasis) 03/2009 - 11/2005
1	Infections 10/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Cachexia 12/2018
1	Anorexia 12/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 11/2014
1	HIV Infections (HIV Infection) 10/2011
1	Injection Site Reaction 02/2011
1	Renal Insufficiency (Renal Failure) 05/2009

Drug/Important Bio-Agent (IBA)

7	Caspofungin (Cancidas)FDA Link 02/2011 - 03/2002
4	odanacatibIBA 10/2020 - 05/2013
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 04/2016
4	pembrolizumabIBA 01/2019 - 01/2017
3	molnupiravirIBA 01/2024 - 01/2023
3	verubecestatIBA 01/2022 - 11/2016
3	CreatinineIBA 10/2020 - 05/2009
3	Cathepsin KIBA 10/2020 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2019
3	Peptides (Polypeptides)IBA 01/2019 - 11/2016
2	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2013
2	EnzymesIBA 01/2019 - 01/2019
2	Collagen Type I (Type I Collagen)IBA 01/2019 - 05/2013
2	Monoclonal AntibodiesIBA 10/2017 - 01/2017
2	Raltegravir Potassium FDA Link 10/2011 - 05/2009
2	EchinocandinsIBA 02/2011 - 05/2005
2	Antifungal AgentsIBA 02/2011 - 05/2005
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	deoxypyridinolineIBA 01/2019
1	AntibodiesIBA 01/2019
1	Docetaxel (Taxotere)FDA Link 12/2018
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2014
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 10/2011
1	Alanine Transaminase (SGPT)IBA 02/2011
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2009

Therapy/Procedure

1	Therapeutics 05/2011